Clinical Practice Guidelines for COVID-19 Management in Children Are Inconsistent
Researchers assessed variations among clinical practice guidelines on the management of COVID-19 in children.
Guidelines
Updated Practice Guideline: IPF and Progressive Pulmonary Fibrosis
A recent update of IPF clinical practice guideline addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
ACC Issues Expert Guidance for Cardiovascular Sequelae After SARS-CoV-2 Infection
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
Assessment of Inhaler Technique in Asthma and COPD Clinical Trials
How often do investigators ensure that participants in asthma and COPD clinical trials use proper inhaler technique — and what can be done to ensure this happens?
Cancer Screening: A Review of Guidelines from ACS, USPSTF
A presentation at the ONA Summit reviewed the cancer screening guidelines from the ACS and USPSTF.
ATS Guideline: Outpatient Management of Pediatric Post-Prematurity Respiratory Disease
How should clinicians handle the outpatient management of infants, children, and adolescents with post-prematurity respiratory disease? A summary of updated recommendations from the American Thoracic Society offers guidance.
Consensus Treatment Outcome Definitions for Chronic Pulmonary Aspergillosis
Consensus definitions for chronic pulmonary aspergillosis treatment outcomes, developed by a panel of international experts convened by CPAnet, were recently published.
Pneumonia Mortality Decreased From Use of ePNa Clinical Support Tool in the ED
How effective is the ePNa, an electronic clinical decision-making support tool, when used in patients with pneumonia in the ED?
New AAD Guideline Seeks to Improve Awareness of Comorbidities Associated With Atopic Dermatitis
New AAD guidelines seek to raise awareness of comorbid disorders in patients with atopic dermatitis among dermatologists and other clinicians.
CDC Releases Interim Guidance on a Novel Treatment Regimen for Drug-Susceptible Tuberculosis
Investigators at the Centers for Disease Control and Prevention evaluated the effect of a novel 4-month regimen for the treatment of drug-susceptible tuberculosis infection.
- Loading...
Loading...
Next post in Tuberculosis
Loading... 
Loading...